This prompted us to extrapolate the knowledge acquired in our previous study on the unique molecular signature of MBTPS2-OI in vitro (14) to characterize the pathogenicity of this novel MBTPS2 variant in causing severe OI. This evidence concerns the gene MBTPS2 and osteogenesis imperfecta.